share_log

FY2024 EPS Estimates for Symrise AG (OTCMKTS:SYIEY) Reduced by Analyst

FY2024 EPS Estimates for Symrise AG (OTCMKTS:SYIEY) Reduced by Analyst

分析师下调了 Symrise AG(OTCMKTS: SYIEY)的 FY2024 每股收益预期
Defense World ·  2023/01/13 03:01

Symrise AG (OTCMKTS:SYIEY – Get Rating) – Investment analysts at Jefferies Financial Group reduced their FY2024 earnings estimates for Symrise in a research report issued to clients and investors on Monday, January 9th. Jefferies Financial Group analyst C. Counihan now expects that the company will earn $1.17 per share for the year, down from their prior estimate of $1.18. The consensus estimate for Symrise's current full-year earnings is $0.88 per share. Jefferies Financial Group also issued estimates for Symrise's FY2025 earnings at $1.23 EPS.

Symrise AG(OTCMKTS: SYIEY — 获取评级)——杰富瑞金融集团的投资分析师在1月9日星期一向客户和投资者发布的一份研究报告中下调了对Symrise的 FY2024 收益预期。杰富瑞金融集团分析师C. Counihan现在预计,该公司今年的每股盈利为1.17美元,低于他们之前估计的1.18美元。对Symrise当前全年收益的共识估计为每股0.88美元。杰富瑞金融集团还发布了对Symrise FY2025 每股收益1.23美元的估计。

Get
获取
Symrise
西姆里斯
alerts:
警报:

Several other equities analysts have also commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Symrise from €107.00 ($115.05) to €110.00 ($118.28) in a research report on Monday, December 5th. The Goldman Sachs Group lowered shares of Symrise from a "buy" rating to a "neutral" rating in a research report on Sunday, November 27th. Finally, Morgan Stanley lowered shares of Symrise from an "equal weight" rating to an "underweight" rating in a research report on Monday, September 26th.

其他几位股票分析师也对该股发表了评论。摩根大通公司在12月5日星期一的一份研究报告中将Symrise股票的目标股价从107.00欧元(115.05美元)上调至110.00欧元(118.28美元)。高盛集团在11月27日星期日的一份研究报告中将Symrise的股票评级从 “买入” 下调至 “中性” 评级。最后,摩根士丹利在9月26日星期一的一份研究报告中将Symrise的股票评级从 “同等权重” 下调至 “减持” 评级。

Symrise Price Performance

Symrise 价格表现

Shares of OTCMKTS:SYIEY opened at $27.95 on Thursday. The company's fifty day moving average is $27.70 and its two-hundred day moving average is $26.79. Symrise has a 1-year low of $22.20 and a 1-year high of $34.67.
OTCMKTS: SYIEY的股票周四开盘价为27.95美元。该公司的五十天移动平均线为27.70美元,其两百天移动平均线为26.79美元。Symrise的1年低点为22.20美元,为1年高点34.67美元。

About Symrise

关于 Symrise

(Get Rating)

(获取评分)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

Symrise AG 提供香料、调味剂、化妆品活性成分和原材料以及功能性成分。它通过两个部门运营:口味、营养与健康和香味与护理。口味、营养与健康部门提供用于食品和饮料生产的功能性成分和风味解决方案;咸味香料;为食品和饮料制造商、婴儿食品和膳食补充剂提供天然和可持续原料;为宠物食品制造商提供产品解决方案和服务;为水产饲料制造商提供为鱼类和虾类养殖场开发解决方案的可持续原料和服务;以及用于食品补充剂和功能性食品的益生菌。

Featured Articles

精选文章

  • Get a free copy of the StockNews.com research report on Symrise (SYIEY)
  • Optimism About Global Demand For Metals Boosts BHP, Other Miners
  • Exxon Mobil Expects Earnings and Cash Flow to Grow
  • Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
  • Is The Great Alibaba Recovery About To Begin?
  • KB Home, Another Reason To Shed Home Building Stocks
  • 免费获取 StockNews.com 关于 Symrise 的研究报告 (SYIEY)
  • 对全球金属需求的乐观情绪提振了必和必拓和其他矿商
  • 埃克森美孚预计收益和现金流将增长
  • Sorrento Therapeutics,Scilex:两只热门制药股正在上涨
  • 阿里巴巴的大复苏即将开始吗?
  • KB Home,抛售房屋建筑股票的另一个理由

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.

接收 Symrise Daily 的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Symrise及相关公司的最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发